1. Home
  2. PETS vs IGC Comparison

PETS vs IGC Comparison

Compare PETS & IGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PetMed Express Inc.

PETS

PetMed Express Inc.

HOLD

Current Price

$1.21

Market Cap

28.4M

ML Signal

HOLD

Logo IGC Pharma Inc.

IGC

IGC Pharma Inc.

HOLD

Current Price

$0.25

Market Cap

32.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PETS
IGC
Founded
1996
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Retail-Drug Stores and Proprietary Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.4M
32.0M
IPO Year
2003
2005

Fundamental Metrics

Financial Performance
Metric
PETS
IGC
Price
$1.21
$0.25
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
130.2K
★ 597.8K
Earning Date
08-13-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 59.09
EPS
N/A
★ N/A
Revenue
★ $273,800,000.00
$1,271,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2.24
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$1.15
$0.24
52 Week High
$4.10
$0.45

Technical Indicators

Market Signals
Indicator
PETS
IGC
Relative Strength Index (RSI) 15.59 34.22
Support Level N/A $0.24
Resistance Level $1.91 $0.30
Average True Range (ATR) 0.04 0.01
MACD -0.00 -0.00
Stochastic Oscillator 3.70 10.21

Price Performance

Historical Comparison
PETS
IGC

About PETS PetMed Express Inc.

PetMed Express Inc is a nationwide direct-to-consumer pet pharmacy and online provider of prescription and non-prescription medications, foods, supplements, supplies, and vet services for dogs, cats, and horses. It markets and sells directly to consumers through its websites, toll-free numbers, and mobile application, offering convenience, price, speed of delivery, and customer service. It provides access to branded pharmaceuticals, generic medications, compounded prescription medications, over-the-counter health and wellness products, prescription and non-prescription food, pharmacy fulfillment, and AutoShip capabilities. Its digital platform offers pet healthcare solutions for chronic conditions, including allergies, arthritis, anxiety, kidney-related conditions, and hyperthyroidism.

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Share on Social Networks: